AcelRx Pharmaceuticals Stock News

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, to

WILMINGTON, Del., April 27, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Tetraphase Pharmaceuticals, Inc. (NASDAQ GS: TTPH) regarding possible.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

WILMINGTON, Del., April 21, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Neon Therapeutics, Inc. (NASDAQ GS: NTGN) regarding possible breaches of.

Dark clouds are looming over Wall Street, and the storm only appears to be intensifying. The market was dealt another blow on Wednesday April 15, with all three of the major U.S. stock indexes sliding

WILMINGTON, Del., April 14, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: E*TRADE Financial Corporation (NASDAQ GS: ETFC) regarding possible breaches.

WILMINGTON, Del., April 02, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Tetraphase Pharmaceuticals, Inc. (NASDAQ GS: TTPH) regarding possible.

The Zacks Analyst Blog Highlights: AcelRx, BioCryst, Build-A-Bear, CACI and Evercore

The Zacks Analyst Blog Highlights: AcelRx, BioCryst, Build-A-Bear, CACI and Evercore

After the Dow sees a quarter as ugly as this year's first quarter, the 124-year old index on average returns 11.8% in the following quarter. There is similar positive trend for the S&P 500 as well.